Archive - September 2018
FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine
FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension
People With Asthma At Higher Risk Of Becoming Obese, Study Suggests
AZ nabs US approval for new leukaemia drug Lumoxiti
New data keeps AbbVie’s star pipeline therapies on track
Gilead targets hep B in half a billion dollar deal with Precision BioSciences
It’s an industry affair – New Medical & Scientific Excellence Awards attracting entrants by the day
‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario